EQUITY RESEARCH MEMO

CMD Medtech

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

CMD Medtech is a US-based medical device consulting firm specializing in FDA regulatory compliance, quality systems, and engineering services, with a strong focus on the cardiovascular sector. Founded in 2018 and headquartered in Irvine, California, the company provides end-to-end development support from concept to market, leveraging deep regulatory expertise and systems engineering. As a certified woman-owned small business, CMD Medtech offers tailored consulting to both startups and established manufacturers. The firm benefits from the growing complexity of FDA regulations and the increasing demand for specialized regulatory support in the medical device industry. With a lean operational model and a seasoned team, CMD Medtech is well-positioned to capture market share in the outsourced regulatory and quality consulting space, particularly as the cardiovascular device market continues to expand.

Upcoming Catalysts (preview)

  • Q3 2026Expansion into new therapeutic areas beyond cardiovascular70% success
  • Q4 2026New FDA guidance on cardiovascular device premarket submissions80% success
  • Q2 2026Strategic partnership with a top medical device manufacturer for recurring consulting engagements60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)